LPL Financial
KERX

LPL Financial’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

LPL Financial’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-36,827
Closed -$138K – 3360
2018
Q2 		$138K Sell
36,827
-16,339
-31% -$79.6K ﹤0.01% 3073
2018
Q1 		$217K Buy
53,166
+8,430
+19% +$39.3K ﹤0.01% 2897
2017
Q4 		$208K Sell
44,736
-2,866
-6% -$15.8K ﹤0.01% 2797
2017
Q3 		$338K Buy
47,602
+5,041
+12% +$36.2K ﹤0.01% 2267
2017
Q2 		$308K Sell
42,561
-6,259
-13% -$39.1K ﹤0.01% 2272
2017
Q1 		$282K Buy
48,820
+38,028
+352% +$208K ﹤0.01% 2242
2016
Q4 		$66K Buy
+10,792
New +$59K ﹤0.01% 2620
2016
Q2 		– Sell
-21,772
Closed -$102K – 3137
2016
Q1 		$102K Sell
21,772
-4,756
-18% -$19K ﹤0.01% 2942
2015
Q4 		$127K Buy
26,528
+8,319
+46% +$39.5K ﹤0.01% 2947
2015
Q3 		$59K Sell
18,209
-14,867
-45% -$99.6K ﹤0.01% 2706
2015
Q2 		$320K Sell
33,076
-4,502
-12% -$48.3K ﹤0.01% 2254
2015
Q1 		$465K Buy
37,578
+1,214
+3% +$15.6K ﹤0.01% 1901
2014
Q4 		$515K Buy
36,364
+4,670
+15% +$72.4K ﹤0.01% 1751
2014
Q3 		$456K Buy
31,694
+6,119
+24% +$93.7K ﹤0.01% 1864
2014
Q2 		$393K Buy
25,575
+707
+3% +$10K ﹤0.01% 1987
2014
Q1 		$424K Buy
24,868
+7,518
+43% +$113K ﹤0.01% 1861
2013
Q4 		$225K Sell
17,350
-4,700
-21% -$56.1K ﹤0.01% 2352
2013
Q3 		$199K Buy
22,050
+3,550
+19% +$31.6K ﹤0.01% 2325
2013
Q2 		$138K Buy
+18,500
New +$145K ﹤0.01% 2286

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIMJS
PKO Investment Management Joint-Stock Warsaw, Poland $1.38B AUM 59.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial's KERX Position: Q3 2018 in Review

LPL Financial sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2018, closing a stake of 36,827 shares — an estimated $138K sold.

LPL Financial first reported a position in KERX in Q2 2013 and held it in 19 quarters. The position peaked at $515K in Q4 2014. 123 funds tracked by Wall St. Rank hold KERX as of Q3 2018.

  • LPL Financial reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • LPL Financial sold 36,827 Keryx Biopharmaceuticals Inc shares in Q3 2018, an estimated $138K.
  • LPL Financial first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 19 quarters.
  • LPL Financial's Keryx Biopharmaceuticals Inc position peaked at $515K in Q4 2014.
  • 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2018.

Based on LPL Financial's 13F filing for Q3 2018, filed 14 Nov 2018.